BRILLANTI STEFANO

Presentation

Professor of Medicine (Gastroenterology) - University of Siena

Director, Liver and Biliary Diseases - AOU Senese

 

Office hours

  • Wednesday from 13:00 to 14:00
    Place: Policlinico Santa Maria alle Scotte Terzo Lotto, piano 8
    Note: Si richiede di concordare il ricevimento via mail, grazie.

Contacts

0577585836 [int.0577585836]

Curriculum Vitae

Teaching activities

Completion accademic year: 2025/2026

Course year: 2 First cycle degree (DM 270) DIETISTIC A.Y. 2024/2025
Course year: 4 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2022/2023
Course year: 4 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2022/2023

Completion accademic year: 2024/2025

Course year: 2 Rheumatology A.Y. 2023/2024
Course year: 2 First cycle degree (DM 270) DIETISTIC A.Y. 2023/2024
Course year: 4 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2021/2022
Course year: 4 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2021/2022
Course year: 3 GERIATRICS A.Y. 2022/2023

Completion accademic year: 2023/2024

Research

Ultime pubblicazioni:

  • Calomino, N., Carbone, L., Kelmendi, E., Piccioni, S.A., Poto, G.E., Bagnacci, G., et al. (2025). Western Experience of Hepatolithiasis: Clinical Insights from a Case Series in a Tertiary Center. MEDICINA, 61(5) [10.3390/medicina61050860]. - view more
  • Stasi, C., Brillanti, S. (2024). Liver Stiffness Values to Predict Occurrence and Recurrence of Hepatocellular Carcinoma. LIFE, 14(3) [10.3390/life14030342]. - view more
  • Pacini, S., Capecchi, P.L., Brillanti, S. (2023). Prospective study on the prevalence of HCV infection in consecutive adult inpatients in a hospital division of Internal Medicine in Tuscany. DIGESTIVE AND LIVER DISEASE, 55(Suppl.1), S30-S30 [10.1016/j.dld.2023.01.057]. - view more
  • Porcelli, B., Bizzaro, N., Fabris, M., Trevisan, M.T., Sciarrone, S.S., Brillanti, S. (2023). Incidental finding of anti-mitochondrial antibody: a neglected entity needing reappraisal. DIGESTIVE AND LIVER DISEASE, 55(7), 994-995 [10.1016/j.dld.2023.04.011]. - view more
  • Dajti, E., Ravaioli, F., Colecchia, A., Marasco, G., Bacchi Reggiani, M.L., Colli, A., et al. (2022). Spleen stiffness measurements predict the risk of hepatic decompensation after direct-acting antivirals in HCV cirrhotic patients. ULTRASCHALL IN DER MEDIZIN, 43(3), 280-288 [10.1055/a-1205-0367]. - view more